Related Experiment Videos
De novo cisplatinum resistance does not influence cellular radiosensitivity
1Department of Medicine, University of Liverpool, U.K.
European Journal of Cancer (Oxford, England : 1990)
|January 1, 1993
Summary
Inherent sensitivity to cisplatinum in human cells does not correlate with their sensitivity to photon or neutron radiation. This suggests acquired resistance mechanisms, not innate traits, influence combined treatment outcomes.
Area of Science:
- Radiobiology
- Cancer Cell Biology
- Radiation Oncology
Background:
- Cisplatin is a widely used chemotherapy agent.
- Understanding cellular responses to combined therapies is crucial for cancer treatment.
- Previous studies suggested a link between cisplatin resistance and radiosensitivity.
Purpose of the Study:
- To investigate the relationship between intrinsic cisplatin sensitivity and radiosensitivity in human cell lines.
- To determine if inherent cisplatin resistance is associated with collateral radioresistance.
Main Methods:
- Cultured human cell lines with varying cisplatin sensitivity were exposed to 4 MeV photons and 62.5 MeV neutrons.
- Cell survival was assessed to determine sensitivity to radiation and cisplatin.
- Statistical analysis compared sensitivities at different survival levels and rank orders.
Main Results:
- No significant correlation was found between intrinsic cisplatin sensitivity and sensitivity to either photon or neutron irradiation.
- Cellular responses to cisplatin did not predict radiosensitivity across the tested cell lines.
Conclusions:
- Innate cisplatin resistance does not confer collateral radioresistance in human cell lines.
- Acquired cisplatin resistance may involve cellular processes that simultaneously increase resistance to ionizing radiation.
- This finding has implications for understanding treatment resistance in cancer therapy.